Characteristic | Variable | Sepsis or septic shock on admission—control group (no ECMO) | Sepsis or septic shock on admission—ECMO group | |
---|---|---|---|---|
N = 4982 | n = 80 | p valuea | ||
Age | Age (days), median (IQR) | 598.5 (103, 2588) | 463 (44, 2546) | 0.48 |
Age group | Infants (birth to 364 days) | 2671 (53.6%) | 45 (56.3%) | 0.95 |
1–4 years | 915 (18.4%) | 14 (17.5%) | ||
5–9 years | 874 (17.5%) | 14 (17.5%) | ||
10–15 years | 522 (10.5%) | 7 (8.8%) | ||
Indigenous status | Indigenous or Torres Strait Islander | 411 (11.8%) | 4 (6.0%) | 0.14 |
Demographics | % male | 2835 (56.9%) | 49 (61.3%) | 0.44 |
Weight, median (IQR) | 11.1 (5.2, 23.0) | 10.55 (3.85, 25.0) | 0.79 | |
Interhospital transfer | 1846 (37.1%) | 53 (66.3%) | < 0.001 | |
Comorbidities | Congenital heart disease | 288 (5.8%) | 8 (10.0%) | 0.11 |
Immunosuppressionb | 801 (16.1%) | 7 (8.8%) | 0.076 | |
Oncology | 733 (14.7%) | 4 (5.0%) | 0.015 | |
Severity on PICU admissionc | Shock on admission | 2347 (47.1%) | 72 (90.0%) | < 0.001 |
Systolic blood pressure, median (IQR) | 93 (80, 108) | 85 (56, 100) | < 0.001 | |
Lactate, median (IQR) | 3.26 (3.26, 3.26) | 4.95 (3.26, 8.05) | < 0.001 | |
Dilated unresponsive pupils | 45 (0.9%) | 2 (2.5%) | 0.14 | |
Cardiac arrest pre-admission | 61 (1.2%) | 13 (16.3%) | < 0.001 | |
Therapy | Intubated | 2537 (51.2%) | 80 (100.0%) | < 0.001 |
Mechanical ventilation in the first hour | 2049 (41.2%) | 68 (85.0%) | < 0.001 | |
Inotropes during 1st hour | 1053 (30.0%) | 57 (76.0%) | < 0.001 | |
Renal replacement | 200 (4.0%) | 41 (51.2%) | < 0.001 | |
High-frequency oscillation ventilation | 180 (3.6%) | 21 (26.3%) | < 0.001 | |
Inhaled nitric oxide | 130 (2.6%) | 23 (28.7%) | < 0.001 | |
Outcome measures | PIM2, mean (SD) | 0.08 (0.14) | 0.25 (0.29) | < 0.001 |
PIM2, median (IQR) | 0.03 (0.01, 0.07) | 0.13 (0.04, 0.35) | < 0.001 | |
Hospital mortality | 501 (10.9%) | 36 (45.0%) | < 0.001 | |
ICU mortality | 415 (8.3%) | 36 (45.0%) | < 0.001 | |
Mean PICU length of stay (hours), median (IQR) | 56.65 (23.33, 135.77) | 240.28 (59.28, 452.79) | < 0.001 | |
Pathogen | Sum of patients with bacterial diagnosis | 2250 (45.2%) | 49 (61.3%) | 0.004 |
Viral coinfection | 532 (10.7%) | 10 (12.5%) | 0.60 | |
No bacterial, fungal, or viral organism identified | 2367 (47.5%) | 25 (31.3%) | 0.004 |